A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19
Journal article published in 2022 by
Oliver J. McElvaney 
,
Natalie L. McEvoy,
Fiona Boland,
Oisín F. McElvaney,
Grace Hogan,
Karen Donnelly,
Oisín Friel,
Emmet Browne,
Daniel D. Fraughen ,
Mark P. Murphy,
Jennifer Clarke,
Orna Ní Choileáin,
Eoin O’Connor,
Rory McGuinness,
Maria Boylan
and other authors.
,
Natalie L. McEvoy,
Fiona Boland,
Oisín F. McElvaney,
Grace Hogan,
Karen Donnelly,
Oisín Friel,
Emmet Browne,
Daniel D. Fraughen ,
Mark P. Murphy,
Jennifer Clarke,
Orna Ní Choileáin,
Eoin O’Connor,
Rory McGuinness,
Maria Boylan
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 